OOIR: Observatory of International Research

Papers

(The median citation count of Best Practice & Research in Clinical Rheumatology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
The importance of functional genomics studies in precision rheumatology	111
Novel therapies – IMID Co-morbidities	108
A review of the advances in understanding the genetic basis of spondylarthritis and emerging clinical benefit	91
Chimeric antigen receptor T-cell (CAR-T) therapy and other cellular immunotherapy treatments for idiopathic inflammatory myopathies	90
CAR T-cell therapy and indications for pediatric rheumatology	67
Predicting and preventing clinical psoriatic arthritis	67
Rehabilitation interventions in osteoarthritis	55
Update of imaging in the assessment of axial spondyloarthritis	55
Raynaud's phenomenon and digital ulceration in systemic sclerosis	52
Epidemiology of rheumatic diseases in tropical populations	50
Rheumatic manifestations of HIV/AIDS	47
The inequity of global healthcare in pediatric rheumatology	44
New age of Lupus Nephritis: Updates in guidelines, biomarkers, and therapies	39
Novel therapies in Sjögren’s disease: A systematic review of the literature	38
Novel therapies for axial spondyloarthritis and future directions	36
Erratum to “Editorial Board” [Best Pract Res Clin Rheumatol (2025) 102094]	35
Oral and maxillofacial manifestations of systemic sclerosis	33
The communication GAP between patients and clinicians and the importance of patient reported outcomes in Systemic Lupus Erythematosus	31
Environmental factors and rheumatic diseases	30
Pathophysiology and immunolgical basis of axial spondyloarthritis	29
Index for PART A	29
Potential therapeutic targets of fibrosis in inflammatory rheumatic diseases	27
Global epidemiology of psoriatic arthritis	26
Exploring the contribution of genetics on the clinical manifestations of systemic lupus erythematosus	26
Genetics of osteoarthritis	26

Decoding pain in axial spondyloarthritis: Mechanisms, management, and future directions	26
Difficult to treat disease in psoriatic arthritis- is it different from axial spondyloarthritis?	26
Unmet need in the treatment of polymyalgia rheumatica and giant cell arteritis	26
Genetics of rheumatoid arthritis	25
Editorial Board	25
Osteoporosis in 2022: Care gaps to screening and personalised medicine	25
The challenges in managing Psoriatic Arthritis in resource poor settings	24
Diagnostic delay in axial spondylarthritis: A lost battle?	24
Where is bone science taking us?	24
Novel therapies and innovation for systemic sclerosis skin ulceration	23
Systemic lupus erythematosus	23
Physiotherapy and occupational therapy in rheumatoid arthritis: Bridging functional and comorbidity gaps	23
Index	22
Classification of systemic lupus erythematosus: From the development of classification criteria to a new taxonomy?	22
Editorial Board	22
Preclinical RA: How to halt its progression	22
Patient-reported outcomes in vasculitis	22
CAR T cell therapy: Autoimmune neurological uses and neurotoxicities	21
Imaging of crystal-induced arthropathies in 2025	21
The role of ultrasound and magnetic resonance imaging in the assessment of musculoskeletal involvement in systemic lupus erythematosus: A review of recent advances and insights	20
The burden of osteoarthritis: Is it a rising problem?	20
Editorial Board	20
Lacrimal and salivary gland ultrasound - how and when to use in patients with primary Sjögren's syndrome	19
Pregnancy & neonatal outcomes in spondyloarthritis	19
Bedside labial salivary gland biopsy (LSGBx: Lip biopsy): An update for rheumatologists	19
Novel biomarkers in RA: Implication for diagnosis, prognosis, and personalised treatment	19
New and future therapies: Changes in the therapeutic armamentarium for SLE	18
Gastrointestinal involvement in systemic sclerosis: A spotlight on small bowel involvement, complications and management	18
Problems with “Problems with opioids beyond misuse”	17
Improving quality of care in systemic sclerosis	17
Imaging rheumatology: Emerging tools and expanding applications	17
Infection associated Vasculitides	16
Malignancy and rheumatic diseases	15
Editorial Board	14
Pregnancy in systemic lupus erythematosus	14
CAR-T cell therapy for ANCA-associated vasculitis: Rationale, current evidence, and future directions	14
Granzyme K+ CD8 T cells in autoimmunity	14
Novel therapies in treatments of SLE	14
Risk for osteoporosis and fracture with glucocorticoids	13
Index	13
Editorial Board	13
What the rheumatologist needs to know about skin biopsy	13
Emerging insights in tropical rheumatology: Challenges, clinical manifestations, and recent advances	13
Clinical assessment of Psoriatic Arthritis	13
Kidney involvement in systemic lupus erythematosus: From the patient assessment to a tailored treatment	12
Best practice and research advances in many aspects of rheumatology	12
Musculoskeletal complications in sickle cell disease: Pathophysiology, diagnosis and management	11
Pharmacogenetics of therapies in rheumatoid arthritis: An update	11
Editorial Board	11
Treatment of rheumatic adverse events of cancer immunotherapy	11

Regenerative methods in osteoarthritis	11
When are patients with osteoarthritis referred for surgery?	11
Exploring osteoarthritis: Unraveling challenges, innovations, and hope for a better future	11
Personalized medicine in rheumatoid arthritis: Combining biomarkers and patient preferences to guide therapeutic decisions	11
Physical rehabilitation interventions for hand function in people with systemic sclerosis	10
Complexity to clarity: Advancing the science and care of systemic sclerosis	10
Pain in osteoarthritis from a symptom to a disease	10
Impact of sex and gender on axSpA diagnosis and outcomes	10
Translational implications of newly characterized pathogenic pathways in systemic lupus erythematosus	10
TNFR2 signalling in inflammatory diseases	9
Practical utilization of sonography for the assessment of muscle diseases in rheumatology	9
Recent targets of osteoarthritis research	9
Osteoporosis evaluation and treatment recommendations in rheumatoid arthritis	9
IgG4-Related disease: From diagnosis to remission	9
Juvenile systemic sclerosis	9
Synovial fluid analysis: Relevance for daily clinical practice	9
Editorial Board	9
CARD9 in the pathogenesis of axial spondyloarthritis	8
Interferonopathies: From concept to clinical practice	8
Preface: Pediatric rheumatology	8
Pain syndromes	8
Introduction to the issue: Cellular therapies in rheumatology	8
Novel Therapy	8
Cutaneous manifestations in myositis syndromes	8
Exploring the role of gut microbes in spondyloarthritis: Implications for pathogenesis and therapeutic strategies	8
The young adult with Juvenile Idiopathic Arthritis (JIA): A clinical review of transition, complications, and psychosocial management	8
Diabetes and osteoporosis – Treating two entities: A challenge or cause for concern?	8
Insights into the genetic landscape of systemic sclerosis	8
Femoroacetabular impingement – What the rheumatologist needs to know	8
Management of glucocorticoid-induced osteoporosis in rheumatic diseases	7
The global burden of fragility fractures – what are the differences, and where are the gaps	7
Novel therapies in axial spondyloarthritis	7
Novel therapies in SSc	7
Pain mechanisms for the practicing rheumatologist	7
Myofascial pain – A major player in musculoskeletal pain	6
Cardiovascular risk in vasculitis	6
Tropical pyomyositis	6
Interstitial lung disease imaging for autoimmune diseases	6
Horizon scan: State-of-the-art therapeutics for psoriatic arthritis	6
Pipeline treatments on psoriatic disease	6
Advances in imaging techniques for Sjogren's disease	6
Bridging clinical phenotypes with molecular mechanisms in autoimmune irAEs: An Etiopathogenic framework	6
Promise of rheumatoid arthritis therapy: From clinical deep remission to drug-free remission	6
Imaging in sarcoid disease	6
Cardiac sarcoidosis: An algorithmic approach to diagnosis and treatment of the “Great Mimicker”	5
The promise of imaging in psoriatic arthritis	5
Non-coding DNA variants for risk in lupus	5
Utility of polygenic risk scores to aid in the diagnosis of rheumatic diseases	5
New developments in ultrasound and MRI imaging of pediatric rheumatic diseases	5
To taper or not to taper biological disease-modifying antirheumatic drugs in axial spondyloarthritis anno 2023: That is the question	5
Magnetic resonance imaging in spondyloarthritis: Friend or Foe?	5
Microbiota and immune dynamics in rheumatoid arthritis: Mechanisms and therapeutic potential	5
Management of pregnant with rheumatoid arthritis: Preconception care, pregnancy and lactation strategies, and maternal-fetal outcomes	4
Screening, monitoring and treatment of interstitial lung disease in systemic sclerosis	4
Practical approaches for clinicians in chronic pain management: Strategies and solutions	4
Osteoporosis and fragility fractures – Why is there still avoidable disability and death?	4
Editorial Board	4
Genetics of vasculitis	4
Vascular ultrasound in rheumatology practice	4
Musculoskeletal manifestations in leprosy	4
“Inflammatory or non-inflammatory pain in inflammatory arthritis – How to differentiate it?”	4
Highlights of advancement in Rheumatoid Arthritis research and clinical practice	4
Challenges in the diagnosis of axial spondyloarthritis	4
How to treat monogenic SLE?	4
Treatment overview of axial spondyloarthritis in 2023	4
CAR T-cell therapy “Living drugs” in systemic lupus erythematosus	4
Cervicogenic headache – How to recognize and treat	4